Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation - video Dailymotion

Skip to player Skip to main content

1 year ago

Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch

Category

Be the first to comment

Add your comment

Recommended

Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'

2 years ago

Snowflake Jumps 8% Pre-Market After Piper Sander Hikes Price Target To $215, Calls It 'High-Conviction Growth Play'

7 months ago

Piper's Sandler's Craig Johnson Puts $6,600 Target On $SPX For 2025

1 year ago

Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition

2 years ago

Charlie Munger Revealed What Was Left On His Bucket List Before He Died

2 years ago

What turns around the value stocks?

2 years ago

Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU

1 year ago

Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know

1 year ago

Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer

2 years ago

Advanced Micro Devices Stock Pops On $6 Billion Buyback Plan, US Tariff Ease

8 months ago

Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows

1 year ago

Microsoft Races To The Top, Hits $3-Trillion Valuation, Challenges Apple's Throne

2 years ago

Billionaire Bill Ackman's Hedge Fund Pershing Square To Go Public At $50 Per Share

1 year ago

"The Second Half Of September Is When The Trouble Tends To Come" - Ryan Detrick, CMT, Carson Group

1 year ago

Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher

2 years ago

Can The S&P 500 Reach $6000 Before Year End? | Jay Woods, CMT, Chief Global Strategist, Freedom Markets

1 year ago

Nike Stock Jumps On Q1 Earnings Beat- 'We Still Have Work Ahead'

3 months ago

Is Managing Volatility Really An Asset Class?

2 years ago

Apple Stock Drops 14% in 2025 As Growth, AI, And China Risks Weigh On Tech Giant

10 months ago

How End Of Month Buy And Sell Imbalances Effected Stock Movements

3 years ago

Housing stocks Not As Quiet As People Think - $TPH $BZH $PHM

3 years ago

Jim Cramer Says Investors Should Check Share Count Before Buying A Stock: 'You Want A Management That Agrees With You'

2 years ago

Is Japan The Right Country To Invest In Right Now? - Jeremy Schwartz, Global Chief Investment Officer @WisdomTreeFunds

3 years ago

Volatility And Momentum In The Market - Cameron Dawson, CIO NewEdge Wealth

1 year ago

Zscaler Q1 Earnings: Revenue Beat, EPS Beat, New AI Opportunities, Shares Slide

1 year ago